Career history of Ian David Postlethwaite
Former positions of Ian David Postlethwaite
| Companies | Position | Start | End |
|---|---|---|---|
| NETSCIENTIFIC PLC | Director/Board Member | 2016-06-14 | - |
| Chief Executive Officer | 2019-04-29 | 2020-04-29 | |
| Director of Finance/CFO | 2016-06-12 | 2020-04-29 | |
| Corporate Secretary | 2016-06-12 | - | |
| Shoreham Port Authority | Director/Board Member | - | 2016-12-30 |
| ALLERGY THERAPEUTICS PLC | Director/Board Member | 2010-11-22 | 2016-06-09 |
| Director of Finance/CFO | 2004-06-30 | 2016-06-09 | |
| Corporate Secretary | 2009-09-30 | 2016-06-09 | |
Ellerman Investments Ltd.
 Ellerman Investments Ltd. Financial ConglomeratesFinance Ellerman Investments Ltd. provides financial services. The private company is based in London, UK. and has subsidiaries in United Kingdom. Ellerman Investments was founded in 1984. | Chief Executive Officer | 1996-12-31 | 2001-12-31 |
PDS Operating Corp.
 PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Director/Board Member | - | - |
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Director/Board Member | - | - |
ProAxsis Ltd.
 ProAxsis Ltd. Pharmaceuticals: MajorHealth Technology ProAxsis Ltd. manufactures and markets pharmaceutical products . It offers clinical research and research and development services. The company was founded by Lorraine Martin and Brian Walker in August 2013 and is headquartered in Belfast, the United Kingdom. | Director/Board Member | - | - |
| Association of Friendly Societies Conference | President | - | - |
Training of Ian David Postlethwaite
| University of Aston | Undergraduate Degree |
Statistics
International
| United Kingdom | 7 |
| United States | 3 |
| 2 |
Operational
| Director/Board Member | 6 |
| Director of Finance/CFO | 2 |
| Corporate Secretary | 2 |
Sectoral
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ALLERGY THERAPEUTICS PLC | Health Technology |
| NETSCIENTIFIC PLC | Health Technology |
| Private companies | 6 |
|---|---|
PDS Operating Corp.
PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Health Technology |
Ellerman Investments Ltd.
Ellerman Investments Ltd. Financial ConglomeratesFinance Ellerman Investments Ltd. provides financial services. The private company is based in London, UK. and has subsidiaries in United Kingdom. Ellerman Investments was founded in 1984. | Finance |
| Shoreham Port Authority | Government |
| Association of Friendly Societies Conference | |
Glycotest, Inc.
Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Electronic Technology |
ProAxsis Ltd.
ProAxsis Ltd. Pharmaceuticals: MajorHealth Technology ProAxsis Ltd. manufactures and markets pharmaceutical products . It offers clinical research and research and development services. The company was founded by Lorraine Martin and Brian Walker in August 2013 and is headquartered in Belfast, the United Kingdom. | Health Technology |
